Pelthos Therapeutics to Present at 38th Annual ROTH Conference
Pelthos Therapeutics (NYSE American: PTHS) announced that CEO Scott Plesha will speak in a fireside chat at the 38th Annual ROTH Conference on March 23, 2026 at 3:00 p.m. PT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Pelthos Therapeutics (NYSE American: PTHS) announced that CEO Scott Plesha will speak in a fireside chat at the 38th Annual ROTH Conference on March 23, 2026 at 3:00 p.m. PT. A live webcast will be available on the company investor site and replayed for 90 days.
Key Figures
- Conference edition
- 38th Annual ROTH Conference
- Event where CEO will speak
- Event date
- March 23, 2026
- Scheduled fireside chat at ROTH
- Presentation time
- 3:00 p.m. Pacific Time
- Time of ROTH fireside chat
- Webcast replay period
- 90 days
- Replay availability after the event
Historical Context
-
Set date and call details for Q4 and full-year 2025 results.
-
Announced CEO presentation at Oppenheimer healthcare conference with webcast access.
-
Secured up to $50 million term loan facility to support product launches.
-
Acquired FDA-approved Xeglyze lice treatment with no ongoing milestone or royalty payments.
-
Appointed experienced finance executive Andrew Einhorn to the board and key committees.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., March 12, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company committed to commercializing innovative therapeutic products for unmet patient needs (“Pelthos”), today announced that CEO Scott Plesha will participate in a fireside chat at the 38th Annual ROTH Conference on March 23, 2026 at 3:00 p.m. Pacific Time.
Investors interested in arranging one-on-one meetings should contact their ROTH representative.
A live webcast of the fireside chat will be available on the News & Events page in the Investors section of the Company’s website at https://pelthos.com. A replay of the webcast will be available for 90 days following the event.
About Pelthos Therapeutics
Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products that address unmet patient needs. ZELSUVMI™ (berdazimer) topical gel,
Contacts
Investors:
LifeSci Advisors, LLC
Mike Moyer, Managing Director
mmoyer@lifesciadvisors.com
Media:
KWM Communications
Kellie Walsh
pelthos@kwmcommunications.com
(914) 315-6072
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.